Presence of bacterial DNA and bacterial peptidoglycans in joints of patients with rheumatoid arthritis and other arthritides
✍ Scribed by Ineke M. Van Der Heijden; Bert Wilbrink; Ilja Tchetverikov; Ingrid A. Schrijver; Leo M. Schouls; Maarten P. Hazenberg; Ferdinand C. Breedveld; Paul P. Tak
- Publisher
- John Wiley and Sons
- Year
- 2000
- Tongue
- English
- Weight
- 855 KB
- Volume
- 43
- Category
- Article
- ISSN
- 0004-3591
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Objective. To investigate the expression and function of Fas ligand (FasL),which can be in a membranebound or soluble form, in the joints of patients with rheumatoid arthritis (RA) and osteoarthritis (OA). Methods. The concentration of soluble FasL (sFasL) in serum and synovial fluid (SF) from 24 O
## Abstract ## Objective To study the presence of bacterial components in the synovial tissue (ST) of patients with advanced rheumatoid arthritis (RA). ## Methods ST was collected during joint surgery from 41 RA patients. Tissue from 39 patients with osteoarthritis (OA), 4 patients with undiffer
Objective. To examine the concentration of the soluble form of the Fas molecule (sFas) in the serum and synovial fluid of patients with rheumatoid arthritis (RA) and osteoarthritis (OA). Methods. The concentration of sFas in the serum of 15 normal subjects and in the synovial fluid and serum of 45
## Abstract ## Objective To assess the association between the initiation of anti–tumor necrosis factor α (anti‐TNFα) therapy and the risk of serious bacterial infections in routine care. ## Methods This was a cohort study of patients with rheumatoid arthritis (RA) in whom specific disease‐modif